Kaléo has launched the “AUVI-Q Speaks Up” campaign to share patients’, caregivers’ and healthcare providers’ stories about life with severe allergies. The company sells AUVI-Q, an epinephrine ...
Richmond, Virginia, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Kaléo, a privately-held U.S. pharmaceutical company has announced a redesign of the AUVI-Q® (epinephrine injection, USP) commercial team structure ...
Richmond-based pharmaceutical company Kaléo has reached a deal with drugstore giant Walgreens to stock its epinephrine injection devices for infants and toddlers as a nationwide shortage of the drugs ...
Kaléo, a privately-held pharmaceutical company, announced that the US Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for AUVI-Q (epinephrine injection, ...
RICHMOND, Va., Aug. 10, 2020 /CNW/ - Kaléo, a privately held U.S. pharmaceutical company, today announced that it has completed negotiations with the pan Canadian Pharmaceutical Alliance (pCPA) for a ...
Kaléo, a global leader in drug-delivery device combinations and auto-injector innovation and the makers of the only epinephrine auto-injector with voice guidance, AUVI-Q ® (epinephrine injection), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results